- Report
- February 2024
- 159 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- February 2024
- 117 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- February 2024
- 120 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- February 2024
- 187 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- February 2024
- 120 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- February 2024
- 116 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- February 2024
- 173 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- February 2024
- 114 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- February 2024
- 179 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 114 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 115 Pages
Asia Pacific
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 115 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 112 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 116 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 114 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 120 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 114 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- April 2023
- 107 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- October 2022
- 110 Pages
Global
From €4262EUR$4,750USD£3,668GBP
- Report
- August 2022
- 115 Pages
Global
From €4262EUR$4,750USD£3,668GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more